BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET
Company Participants
Roderick de Greef - CFO
Mike Rice - President and CEO
Conference Call Participants
Paul Knight - Janney
Faizzan Ahmad - H.C. Wainwright
William March - Spring City Partners
Operator
Good afternoon ladies and gentlemen and welcome to the Q3 2019 BioLife Solutions Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]
As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Roderick de Greef, Chief Financial Officer. You may begin.
Roderick de Greef
Thank you, JP. Good afternoon, everyone, and thank you for joining us for the BioLife Solutions conference call to review the operating and financial results for the third quarter of 2019.
Earlier this afternoon, we issued a press release which summarizes our financial results for the three and nine months ended September 30, 2019. We also issued a press release this afternoon, announcing our asset purchase of Custom Biogenic Systems or CBS.
As a reminder, during this call, we will make certain projections and other forward-looking statements regarding future events or the future financial performance of the company. These statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations. For a detailed discussion of the risks and uncertainties that affect the Company's business and that qualify as forward-looking statements, I refer you to our periodic and other public filings filed with the SEC.
Company projections and forward-looking statements are based on factors that are subject to change and therefore these statements speak only as of the date they are
- Read more current BLFS analysis and news
- View all earnings call transcripts